Study of SM-88 in Advanced Cancers
NCT02562612
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Study was never initiated. Never established sites or enrolled subjects.
Conditions
Breast Cancer
Interventions
DRUG:
SM-88
Sponsor
Tyme, Inc